- Home
- MACI vs CDTX Comparison
MACI vs CDTX Comparison
Compare MACI & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MACI
- CDTX
- Stock Information
- Founded
- MACI 2024
- CDTX 2012
- Country
- MACI United States
- CDTX United States
- Employees
- MACI N/A
- CDTX N/A
- Industry
- MACI
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MACI
- CDTX Health Care
- Exchange
- MACI NYSE
- CDTX Nasdaq
- Market Cap
- MACI 221.6M
- CDTX 259.0M
- IPO Year
- MACI 2024
- CDTX 2015
- Fundamental
- Price
- MACI $10.32
- CDTX $18.63
- Analyst Decision
- MACI
- CDTX Strong Buy
- Analyst Count
- MACI 0
- CDTX 8
- Target Price
- MACI N/A
- CDTX $38.50
- AVG Volume (30 Days)
- MACI 9.3K
- CDTX 92.3K
- Earning Date
- MACI 01-01-0001
- CDTX 05-08-2025
- Dividend Yield
- MACI N/A
- CDTX N/A
- EPS Growth
- MACI N/A
- CDTX N/A
- EPS
- MACI N/A
- CDTX N/A
- Revenue
- MACI N/A
- CDTX $302,000.00
- Revenue This Year
- MACI N/A
- CDTX N/A
- Revenue Next Year
- MACI N/A
- CDTX N/A
- P/E Ratio
- MACI $44.17
- CDTX N/A
- Revenue Growth
- MACI N/A
- CDTX N/A
- 52 Week Low
- MACI $9.95
- CDTX $10.14
- 52 Week High
- MACI $10.35
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- MACI N/A
- CDTX 39.70
- Support Level
- MACI N/A
- CDTX $19.97
- Resistance Level
- MACI N/A
- CDTX $22.80
- Average True Range (ATR)
- MACI 0.00
- CDTX 1.47
- MACD
- MACI 0.00
- CDTX -0.21
- Stochastic Oscillator
- MACI 0.00
- CDTX 2.90
About MACI MELAR ACQUISITION CORP. I
Melar Acquisition Corp I is a blank check company.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.